Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples - ScienceDirect
Clinical Trial Designs: Basket, Umbrella & Platform Trial Designs - Part II | Credevo Articles
Basket Trial Design - YouTube
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both | NEJM
Basket Trials and Umbrella Trials (Chapter 8) - Introduction to Adaptive Trial Designs and Master Protocols
Basket Trials: Features, Examples, and Challenges
Frontiers | Design and analysis of umbrella trials: Where do we stand?
Basket Trials for Cancer Treatments – Cofactor Genomics
Clinical trial design: Past, present, and future in the context of big data and precision medicine - Li - 2020 - Cancer - Wiley Online Library
Clinical Trial Designs: Basket, Umbrella & Platform Trial Designs - Part II | Credevo Articles
Clinical trial designs for the era of molecular oncology. (a) Umbrella... | Download Scientific Diagram
Master Protocols for Clinical Trials – Biostatistics & Bioinformatics Services
Basket Clinical trial-Tumour agnostic design where patients are... | Download Scientific Diagram
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both | NEJM
Basket Clinical Trial Designs: The Key to Testing Innovative Therapies is Innovation in Study Design and Conduct - ACRP
Adaptive Designs for Clinical Trials | Precision for Medicine
Basket Trials and Umbrella Trials (Chapter 8) - Introduction to Adaptive Trial Designs and Master Protocols
Basket Trial Design - YouTube
New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response | European Respiratory Society
Life | Free Full-Text | Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials
An overview of precision oncology basket and umbrella trials for clinicians - Park - 2020 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Basket, umbrella and platform trials: a regulatory perspective
